Compare Revolution Medicines Inc. Common Stock (RVMD) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revolution Medicines Inc. Common Stock vs Trade Desk Inc — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B), while Trade Desk Inc trades at $12.08 (market cap $5.83B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 6.9× Trade Desk Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Trade Desk Inc for 72 Days on average.
| RVMD | TTD | |
|---|---|---|
Market Cap | $40.32B | $5.83B |
Volume | 4,855,734 | 15,864,392 |
Sector | Health | Media |
52-Week High | $221.15 | $54.13 |
52-Week Low | $47.50 | $11.92 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $37.02B | $4.78B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
The Trade Desk (TTD) trades at $12.34, up 2.07% today but remains down significantly from recent highs. Technical indicators show a bearish trend with mixed momentum signals. Fundamentally, the company maintains strong profitability with 76.87% gross margins and 15.44% ROE, though revenue growth has slowed to 3% in 2026. Recent news highlights competitive pressures from Amazon and Alphabet while the company navigates workforce reductions and slower CTV growth.
Investment outlook remains cautious with analyst consensus at $14.72 target price representing 19% upside potential. Key opportunities include TTD's dominant position in programmatic advertising and healthy cash flow generation. Primary risks involve intensifying competition from tech giants, slowing revenue growth, and execution challenges during restructuring. The stock presents a value opportunity for patient investors if competitive pressures ease.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
